The instrument will be based on iGene’s liquid chip probe hybrid gene capture technology TargetSeq and multiple PCR amplification technology MultipSeq. It aims at enterprises, hospitals and research institutions interested to customize and develop genetic testing kits.
China Bio news release, February 28, 2017